A study is underway to evaluate new diagnostic tests for tuberculosis (TB) in its early stages. The ERASE-TB study will enroll 2100 household contacts, people living in close proximity with someone recently diagnosed with TB.
The current diagnostic tests for TB are not very specific, sensitive, or accurate when detecting TB in the early stages of the infection. This means that they can often miss cases of TB, or give false positive results.
The ERASE-TB study aims to develop new diagnostic tests that are more accurate and reliable for detecting TB in its early stages. This would help to improve early diagnosis and treatment, which is essential for preventing the spread of the disease. Discover more about the latest on the study in ERASE-TB's World Lung Day newsletter and in this film.
The study is funded by the EDCTP and the European Union. The EDCTP is a partnership between the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP).
More: https://www.erase-tb.co.uk/
